Fermenta Biotech Ltd · BSE:FERMENTA
Fermenta Biotech — Shareholder Meeting (August 2026)
20 slides from Fermenta Biotech's shareholder meeting presentation, Aug 11, 2026
Slide 1: Filing cover letter for 74th AGM presentation
August 11, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, Dalal Street, Fort, G Block, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai 400 051 Scrip Code: 506414 Trading Symbol: FERMENTA Dear Sir, Sub.: Presentation f
Slide 2: 74th Annual General Meeting: Innovation, Scale, Focus
Innovation 74th Annual General Meeting Focus of Scale Shareholders 11 August 2026
Slide 3: 2025-26 was a year of operating momentum
2025-26 was a year of operating momentum, renewed strategic conviction, and capital commitment 74th Annual General Meeting | 2
Slide 4: Talking Points
Talking Points Innovation: Patent, CEP and New Capacity Granted plant-source Vitamin D3 process patent, EDQM CEP for D3 100 SD, and ₹110 crore of new Dahej capacity approved Scale: Record Topline, Strong Operating Leverage Consolidated revenue rose to a record ₹548 crore, up 14% from ₹481 crore in F
Slide 5: Recent Timeline
Recent Timeline Manufacturing & technology breakthroughs Backward integration & strategic growth ₹ 548 Cr Human nutrition innovations ₹ 481 Cr Plant-source Vitamin D3 & therapeutics 2026 Biocatalysis & green chemistry | global certifications ₹ 407 Cr Granted the Indian ₹ 347 Cr 2025 process patent f
Slide 6: The Opportunity
The Opportunity Unlocking growth: Fermenta’s unique position to meet evolving health and nutrition demands worldwide India Global Innovation Drivers ✓ Preventive health ✓ Nutritional supplements ✓ Plant-source actives awareness ✓ Ageing drives vitamin D ✓ Biocatalysis & green chemistry ✓ Growing mid
Slide 7: Strategy Map
Strategy Map Our Mission To harness our expertise in Innovation Chemistry and complex manufacturing at scale, delivering science-validated, leading-class solutions across nutrition, health and green chemistry, while creating lasting value for customers, society and investors Financial Financial Perf
Slide 8: Manufacturing and R&D
Manufacturing and R&D Enzymes and APIs including Vitamin D3 Customized premix plant Kullu Multiple global regulatory certifications Dedicated Vitamin D3 with Himachal Pradesh backward integration for cholesterol Collaboration with toll manufacturer for Vitamin Multiple global regulatory Dahej D3 500
Slide 9: Strategic Partnership Ecosystem
Strategic Partnership Ecosystem The Collaboration Strategic Value Global healthcare company Vitamin D awareness campaigns Extends our reach to healthcare specializing in diagnostics, Print and audiovisual educational materials professionals and patients medical devices, and nutrition Premier food te
Slide 10: FBL Certifications
FBL Certifications Comprehensive certifications demonstrate our commitment to meet diverse customer needs and global standards of quality, safety, sustainability, and ethical production. Adherence to stringent guidelines for GMP approval for dietary supplements European pharmaceutical markets Confir
Slide 11: R&D Focus Areas & Achievements
R&D Focus Areas & Achievements Focus Key Achievements Future Directions Calcifediol commercialization API Product pipelines Commercialized 11 products including Cholesterol, Lanolin derivatives VITADEE Green® Process improvement Enhanced Phenyramidol HCl process VITADEE SD (Spray Dried) Yield enhanc
Slide 12: Strategic Portfolio for Future Growth
Strategic Portfolio for Future Growth f Spray-Dried Vitamin D3 VITADEE Green® Calcifediol Customized Premixes ✓ 100,000 IU/g pharmaceutical-grade ✓ Plant-based Vitamin D3 with ✓ Next-generation Vitamin D ✓ Equipped with advanced instrumentation technology with CEP certification clean-label for vegan
Slide 13: Diversified Markets, Balanced Customers
Diversified Markets, Balanced Customers Revenue balanced across India, Europe, North America and other regions, and a widening customer base, give Fermenta a low-concentration platform for resilient, durable growth Resilient revenue streams Geographical revenue mix Excluding value unlocking Revenue
Slide 14: Fermenta's Core Proposition
Fermenta’s Core Proposition Society Advance global health and preventive care through science-validated ingredients and actives Support life and productivity across human and animal populations Address environmental challenges through green chemistry and sustainable processes Best-in-class, science-
Slide 15: Key Numbers
Key Numbers Record Revenue, Stronger Cash Generation & Steady Deleveraging (₹ Crore) 548 (₹ Crore) 481 117 407 105 Revenue scales new 359 347 Cash flow from 93 heights operations 43 41 122 122 236 205 210 206 EBITDA holds on 193 70 Net fixed assets operating leverage 39 26 76 70 236 217 PAT stays fi
Slide 16: Revenue Mix (Consolidated)
Revenue Mix (Consolidated) Businesses beyond Nutrition now 15% of revenue as real-estate unlocking completes (₹ Crore) 0.4% FY23 FY24 FY25 FY26 9% 5% 13% 18% 4% 4% 9% Nutrition Business 248 217 35 0 4 35 6% 5% 4% 6% 8% 3% 3% 6% Vitamin D3 - Human Nutrition 163 141 228 293 6% 1% 2% 8% 8% Vitamin D3 -
Slide 17: Financials: Income Statement, Balance Sheet, Cash Flow
Financials Income Statement: Operating Leverage Sustains Profitability Income Statement (₹ Crore) Balance Sheet (₹ Crore) Cash Flow (₹ Crore) Income grew 14% and profit before Gross debt held flat while net debt roughly Operating cash flow more than doubled exceptional items and tax rose 7%, holding
Slide 18: Ratios
Ratios Resilient Returns | Lower Leverage | Stronger Cover FY23 FY24 FY25 FY26 LIQUIDITY ▪ EBITDA margin at 23.3%, held well above the FY23-24 reset Current 1.2 1.4 1.58 1.86 Quick 0.5 0.8 0.87 0.99 ▪ ROE 16.5% and ROA 10.1%: returns ASSET MANAGEMENT moderated from the FY25 peak Asset turnover 0.5 0
Slide 19: Takeaway
Takeaway Leadership Position Among the world’s top 3 Vitamin D3 manufacturers, serving 400+ customers across 60+ countries Innovation & Manufacturing Excellence 75+ years expertise with 100+ scientists and 600+ employees, backed by state-of-the-art, certified facilities and a granted plant-source D3
Slide 20: Thank you
Thank you Contact info@fermentabiotech.com Fermenta Biotech Ltd